Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time.

The study will include adults without diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS.

Researchers will study whether participants develop diabetes after surgery and whether this risk changes according to the type of pancreatic resection.

Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.

Eligibility criteria

Qualifiers

Adult patients (≥18 years)

No diabetes mellitus at baseline

Undergoing partial, near-total, or total pancreatectomy at the study center

Availability of clinical and metabolic data according to study component

Disqualifiers

Diabetes mellitus at baseline

Age <18 years

Missing key clinical data precluding eligibility assessment or primary outcome evaluation

Refusal or inability to provide informed consent for the prospective component, where applicable

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

579 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

European Foundation for the Study of Diabetes

Collaborator